(Q39397196)

11 September 2017

Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma (English)

1 reference

11 September 2017

1 reference

1 reference

4

1 reference

11 September 2017

Lihua Li

1

1 reference

PubMed ID

22330340

11 September 2017

Aaron L Sarver

series ordinal

2

1 reference

PubMed ID

22330340

11 September 2017

Setara Alamgir

series ordinal

3

1 reference

11 September 2017

13 February 2012

1 reference

11 September 2017

Laboratory Investigation

1 reference

11 September 2017

92

1 reference

11 September 2017

4

1 reference

11 September 2017

571-583

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2012.10

11 September 2017

0 references

cites work

Trends in cancer incidence among children in the U.S.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Rhabdoid tumors of soft tissues: A clinicopathologic study of 26 cases enrolled on the intergroup rhabdomyosarcoma study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Intergroup Rhabdomyosarcoma Study: update for pathologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Molecular genetics and pathogenesis of rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Inhibition of rhabdomyosarcoma's metastatic behavior through downregulation of MET receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MicroRNA expression signature of human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

S-MED: sarcoma microRNA expression database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Highly sensitive and specific microRNA expression profiling using BeadArray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Normalization and analysis of cDNA microarrays using within-array replications applied to neuroblastoma cell response to a cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

A PANorama of PAX genes in cancer and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

A Pax3/Dmrt2/Myf5 regulatory cascade functions at the onset of myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Myogenic factors that regulate expression of muscle-specific microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

Infants younger than 1 year of age with rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.10

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2012.10

1 reference

11 September 2017

1 reference

PubMed ID

22330340